Royal care Super Speciality Hospitals

1 M

As of May 11, 2025, Royal care Super Speciality Hospitals share price is INR 0.00 per share and the face value is INR 10.00 per share. The lot size of Royal care Super Speciality Hospitals is 0 shares. The 52 week high for Royal care Super Speciality Hospitals is INR 0.00, while the 52 week low is INR 0.00

About Royal care Super Speciality Hospitals

A Comprehensive Overview of Price & Journey
Understanding Royal care Super Speciality Hospitals Inception and Growth
SHOW MORE...

About Royal care Super Speciality Hospitals

IPO Details, Price movement

Performance Highlights for FY 2023-24

  • The revenue from operations for the hospital was Rs. 332.73 Crores compared to the previous year, which stood at Rs. 305.48 Crores, an increase of 8.9%.

  • The revenue from operations is generated by four components, and these are inpatient revenue, Outpatients Revenue, Pharmacy Sales and Dietary.

  • The Revenue generated by these four in FY24 is Rs. 246.39 Crores, 50.26 Crores, 29.01 Crores and 7.05 Crores, respectively.

  • The profit before tax increased by 56.2% from 15.56 Crores in FY23 to Rs. 24.3 Crores in FY24.

  • The Profit After Tax for the year is Rs. 24.48 Crores  

  • Earning Per Share (EPS) for FY24 is Rs. 1.43.

  • Total Assets for the Hospital Stood to Rs. 545.26 Crores.

  • There is a cash inflow of Rs. 87.18 Crores from operating activities and Rs. 25.29 Crores from financing activities.

  • The company spent cash of Rs. 90.26 Crores on investing activities.

  • This hospital is good to invest in for the investors as it generates good profits and looks financially healthy.

SHOW MORE...

Fundamentals

Market Cap (in cr.)
₹ 0
P/E Ratio
0.00
P/B Ratio
0.00
Debt to Equity
1.26
ROE (%)
173.71
Book Value
11.99
Face Value
10.00
Total Shares
171017768
Category
Unlisted Shares
Unlisted CMP
₹ 0 / Share
Lot Size
0 Shares
52 Week High
₹0.00
52 Week Low
₹0.00
Depository
0
PAN Number
AAGCR1968R
ISIN Number
INE02C801010
CIN
U85100TZ2012PLC018984
Sector
Health Care

Financials

P&L Statement 2021 2022 2023 2024
Revenue - 301.15 305.49 332.73
Other Income - 4.22 5.16 5.19
COGS - 71.23 68.57 72.76
Gross Profit - 234.15 242.08 265.17
Total Expense - 161.93 175.29 194.17
EBIDTA - 72.22 66.79 71.00
D&A - 23.72 24.39 24.53
EBIT - 48.50 42.40 46.47
Interest Expense - 27.17 26.84 22.15
PBT - 21.32 15.56 24.32
TAX - 0.09 -0.11 -0.17
PAT - 21.23 15.68 24.48
Diluted EPS - 1.29 0.95 1.43
Basic EPS - 1.29 0.95 1.43
Total income 0.00 305.37 310.65 337.92
ASSETS
CURRENT ASSETS 2021 2022 2023 2024
Cash and Cash Equivalents - 8.31 5.04 27.25
Trade Payables - 9.12 16.86 23.44
Inventory - 6.51 9.01 13.31
Other Current Assets - 14.40 14.25 9.51
Total Current Assets 0.00 38.34 45.16 73.51

NON CURRENT ASSETS 2021 2022 2023 2024
Plant Property and Equipment - 341.25 343.69 411.15
Long Term Investment - 1.17 1.16 1.16
Other Non Current Assets - 24.87 30.64 59.45
TOTOAL NON CURRENT ASSSETS 0.00 367.29 375.49 471.76

Total Assets 0.00 405.63 420.65 545.27

CURRENT LIABILITES 2021 2022 2023 2024
TRADW Payable - 6.16 12.47 29.99
Other Current Liab - 62.92 60.43 67.48
Total Current Liab 0.00 69.08 72.90 97.47

NON CURRENTLIABILITIES 2021 2022 2023 2024
Long Term Debt - 212.50 203.46 244.58
Deffered Tax Liab - - - -
Other Non Current Liab - 6.01 10.60 8.50

LIABILITIES
EQUITY 2021 2022 2023 2024
Share Capital - 164.38 164.38 171.02
Reserves And Surplus - - - -
Other Equity - -46.34 -30.67 23.70
Retained Earnings - - - -
share Equity 0.00 118.04 133.71 194.72

Total Liabilities 0.00 336.55 347.77 447.80

CASH FLOW STAT 2021 2022 2023 2024
Cash Flow from operating - 83.40 58.96 87.18
Cash Flow from financing - -35.18 -36.33 25.29
Cash Flow from investing - -43.22 -25.90 -90.27
Net cash flow 0.00 5.00 -3.27 22.20

Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Shareholding Pattern
2025
Name Designation Share %
Promoters NA 13.51%
Other NA 86.49%
Events
Name Date Details
No events available.
Promoters or Management
Name Designation Linkedin Profile
Dr. K. Madeswaran Chairman & MD
Dr. K. Chockalingam Director
Sri. T. Balachander Director & CFO
Documents
Royalcare Super Speciality Hospitals Unlisted shareOne Pager

Frequently Asked Questions

3. What is the lock-in period of Royal care Super Speciality Hospitals/Pre-IPO shares after the shares gets listed?

  • The lockin period is of 6 months for pre-ipo investors i.e. they cannot sell their shares for 6 months after they get listed. However, they can definitely sell the shares in pre-ipo market before they get listed.

4. What is the average ticket size for investing in unlisted shares?
5. How to check credit of Royal care Super Speciality Hospitals/Pre-IPO shares?
6. How is valuation of Royal care Super Speciality Hospitals/Pre-IPO shares is decided?
9. Difference Between Unlisted Company & Listed Company?
10. Short-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
11. Long-term Capital Gain taxes to be paid on Unlisted Shares/Pre-IPO shares?
12. Applicability of Taxes on Unlisted Shares/Pre-IPO shares once it is listed?
13. IS PRE IPO market same as grey market?
14. Who sells private shares?
15. Investing in Royal care Super Speciality Hospitals legal in India?

Related News